Purchase Order 75N90024P00237

Award Date 2/22/24
Potential Completion Date 3/22/24
Potential Value $11K
Federal Agency
NIH Clinical Center
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,064 purchase order to Qiagen, LLC. Under this firm fixed price contract, Qiagen will provide products or services to the NIH Clinical Center in Germantown, Maryland between September 2023 and September 2024. As a division of Qiagen N.V., Qiagen, LLC will leverage its parent company's expertise in sample and assay technologies to support the NIH Clinical Center's biomedical research and...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $203,604.25 firm-fixed-price purchase order to Qiagen, LLC for the maintenance of Qiagen instruments used for clinical testing by the Molecular Diagnostics and Molecular Hematology Sections. The contract has a period of performance through April 14, 2024 and was not set aside for any specific business category. Qiagen, LLC is a division of the international provider Qiagen N.V., which has a...
This purchase order award from the Department of Health and Human Services' National Institutes of Health Clinical Center to Qiagen, LLC is for $10,847.20 to support library preparation in next generation sequencing assays for clinical center patients. Qiagen will provide products and services for DNA/RNA extraction and sample preparation to support the agency's biomedical research and public health programs. As an international provider of molecular diagnostics technologies, Qiagen has...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,433 firm fixed price purchase order to Qiagen, LLC for unspecified products or services. Qiagen, a subsidiary of Qiagen N.V., will perform the contract from its location in Bethesda, Maryland over a one year period ending August 2024. No additional details were provided regarding the original solicitation or scope of work. However, based on the funding agency, the products or services are...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The $111,768.00 contract does not have a set-aside designation. Qiagen, a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, is delivering products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. Qiagen holds several...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $37,877 purchase order to Qiagen, LLC for reagents and consumables. Qiagen, a division of Qiagen N.V., will provide the requested products to the agency in Germantown, Maryland over a two month period under a firm fixed price contract. No additional details were provided on the original solicitation, major subcontractors, or high-level context regarding the funding agency's programs. The award...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
This is a $10,768 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the provision of Qiagen's clinical insight analysis products and services, with a period of performance through September 28, 2026. Qiagen, a foreign-owned, for-profit manufacturer, specializes in molecular diagnostics, scientific equipment, and bioinformatics solutions. The...
This is a $17,029.90 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The award does not have a set-aside designation. Qiagen provides a range of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is associated with a larger Qiagen indefinite delivery vehicle that...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $10,037.40 contract will provide the NIH with Qiagen's sample and assay technologies to support the agency's biomedical research, public health, and healthcare programs. The contract does not have a set-aside designation. Qiagen has a history of providing a range of products and services to federal...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $11,449.80 firm fixed price purchase order to Qiagen, LLC for the performance of clinical testing in the molecular diagnostics laboratory of the microbiology service. Qiagen will provide products and services to support the required testing through March 2024. No set-aside designation was applied to this award. Qiagen is an international provider of sample and assay technologies for molecular diagnostics and applied testing. Through past contracts, Qiagen has demonstrated its ability to meet the specialized product and service needs of federal health agencies like the National Institutes of Health.

Generated 2/23/24, 11:30 AM